Det antal patienter med hepatitis C, som behandlingen virkede på, var omtrent det samme for Alpheon og Roferon- A i den kliniske undersøgelse.
The number of patients with hepatitis C responding to treatment with Alpheon and Roferon-A was similar in the clinical study.